[go: up one dir, main page]

DK1678185T3 - 2,3-dihydro-6-nitroimidazo[2,1-b]oxazolforbindelser til behandling af tuberkulose - Google Patents

2,3-dihydro-6-nitroimidazo[2,1-b]oxazolforbindelser til behandling af tuberkulose

Info

Publication number
DK1678185T3
DK1678185T3 DK04793412T DK04793412T DK1678185T3 DK 1678185 T3 DK1678185 T3 DK 1678185T3 DK 04793412 T DK04793412 T DK 04793412T DK 04793412 T DK04793412 T DK 04793412T DK 1678185 T3 DK1678185 T3 DK 1678185T3
Authority
DK
Denmark
Prior art keywords
nitroimidazo
tuberculosis
dihydro
treatment
oxazole compounds
Prior art date
Application number
DK04793412T
Other languages
Danish (da)
English (en)
Inventor
Hidetsugu Tsubouchi
Hirofumi Sasaki
Motohiro Itotani
Yoshikazu Haraguchi
Shin Miyamura
Makoto Matsumoto
Hiroyuki Hashizume
Tatsuo Grand Kawauch Tomishige
Masanori Kawasaki
Kinue Ohguro
Takumi Sumida
Takeshi Hasegawa
Kazuho Tanaka
Isao Takemura
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of DK1678185T3 publication Critical patent/DK1678185T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK04793412T 2003-10-31 2004-10-29 2,3-dihydro-6-nitroimidazo[2,1-b]oxazolforbindelser til behandling af tuberkulose DK1678185T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2003373206 2003-10-31
JP2004111720 2004-04-06
PCT/JP2004/016492 WO2005042542A1 (en) 2003-10-31 2004-10-29 2,3-dihydro-6-nitroimidazo (2,1-b) oxazole compounds for the treatment of tuberculosis

Publications (1)

Publication Number Publication Date
DK1678185T3 true DK1678185T3 (da) 2008-12-08

Family

ID=34554779

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04793412T DK1678185T3 (da) 2003-10-31 2004-10-29 2,3-dihydro-6-nitroimidazo[2,1-b]oxazolforbindelser til behandling af tuberkulose

Country Status (19)

Country Link
US (1) US8163753B2 (ru)
EP (1) EP1678185B1 (ru)
KR (1) KR100851802B1 (ru)
AR (1) AR046777A1 (ru)
AT (1) ATE410430T1 (ru)
AU (1) AU2004285811B2 (ru)
BR (1) BRPI0414909A (ru)
CA (1) CA2539335A1 (ru)
CY (1) CY1108481T1 (ru)
DE (1) DE602004017037D1 (ru)
DK (1) DK1678185T3 (ru)
ES (1) ES2314460T3 (ru)
MY (1) MY146646A (ru)
PL (1) PL1678185T3 (ru)
PT (1) PT1678185E (ru)
RU (1) RU2365593C2 (ru)
SI (1) SI1678185T1 (ru)
TW (1) TWI335331B (ru)
WO (1) WO2005042542A1 (ru)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004285811B2 (en) * 2003-10-31 2008-06-12 Otsuka Pharmaceutical Co., Ltd. 2,3-dihydro-6-nitroimidazo (2,1-B) oxazole compounds for the treatment of tuberculosis
JP5188807B2 (ja) * 2004-10-18 2013-04-24 イーライ リリー アンド カンパニー ｍＧｌｕＲ３受容体アンタゴニストとして用いるための１−（ヘテロ）アリール−３−アミノ−ピロリジン誘導体
WO2006125181A2 (en) * 2005-05-19 2006-11-23 Xenon Pharmaceuticals Inc. Piperidine derivatives and their use as stearoyl-coa desaturase modulators
US7709516B2 (en) * 2005-06-17 2010-05-04 Endorecherche, Inc. Helix 12 directed non-steroidal antiandrogens
EP1906926B1 (en) * 2005-07-28 2010-12-01 Otsuka Pharmaceutical Co., Ltd. Pharmaceutical composition comprising 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole derivatives
JP2007106746A (ja) * 2005-09-13 2007-04-26 Tosoh Corp 新規アリールホモピペラジン類、またはその塩と製造方法
TWI368509B (en) * 2005-10-05 2012-07-21 Otsuka Pharma Co Ltd Antituberculous therapeutic drugs and kit containing the same
JP5105818B2 (ja) * 2005-10-05 2012-12-26 大塚製薬株式会社 医薬組成物
US7977359B2 (en) 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
US8399666B2 (en) 2005-11-04 2013-03-19 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
GB2431927B (en) * 2005-11-04 2010-03-17 Amira Pharmaceuticals Inc 5-Lipoxygenase-activating protein (FLAP) inhibitors
JP2009521464A (ja) * 2005-12-23 2009-06-04 ノバルティス アクチエンゲゼルシャフト ニトロイミダゾール化合物
AU2007252198A1 (en) * 2006-05-22 2007-11-29 Merck Frosst Canada Ltd. Cyclic amine derivatives as inhibitors of stearoyl-coenzyme A delta-9 desaturase
WO2008008480A2 (en) 2006-07-12 2008-01-17 Cumbre Pharmaceuticals Inc. Nitroheteroaryl-containing rifamycin derivatives
AR070301A1 (es) 2007-05-08 2010-03-31 Otsuka Pharma Co Ltd Compuesto epoxi y metodo para producir el mismo
CN101965353B (zh) * 2008-03-26 2014-12-17 丹诺医药(苏州）有限公司 共价连接到取代苯基噁唑烷酮的双环硝基咪唑类
US8546431B2 (en) 2008-10-01 2013-10-01 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
WO2010081851A1 (en) 2009-01-14 2010-07-22 Genoscience Pharma Piperidin-4-ylpiperazine compounds for the treatment of hcv infection
RU2540860C2 (ru) * 2009-07-31 2015-02-10 Глоубал Элаенс Фор Тб Драг Дивелопмент Нитроимидазооксазиновые и нитроимидазооксазольные аналоги и их применение
JP5916739B2 (ja) 2011-04-15 2016-05-11 大塚製薬株式会社 ６，７−ジヒドロイミダゾ［２，１−ｂ］［１，３］オキサジン化合物
KR20130083592A (ko) * 2012-01-13 2013-07-23 현대약품 주식회사 치환된 피페리딘 유도체 및 이의 제조방법
KR101650716B1 (ko) * 2012-11-22 2016-08-24 한국화학연구원 바이시클릭니트로이미다졸 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 결핵의 예방 또는 치료용 약학적 조성물
ES2707362T3 (es) * 2013-10-04 2019-04-03 Council Scient Ind Res 6-nitro-2,3-dihidroimidazo [2,1-b] oxazoles y un procedimiento de preparación de los mismos
KR102582563B1 (ko) * 2014-06-20 2023-09-25 재단법인 한국파스퇴르연구소 항감염 화합물
EP2974729A1 (en) 2014-07-17 2016-01-20 Abivax Quinoline derivatives for use in the treatment of inflammatory diseases
AR101704A1 (es) * 2014-08-28 2017-01-04 Otsuka Pharma Co Ltd Compuestos heterocíclicos fusionados
MX383020B (es) * 2014-10-01 2025-03-13 Henkel Ag & Co Kgaa Aceleradores de curado para composiciones curables anaerobicas.
US9822126B1 (en) 2014-10-21 2017-11-21 Council Of Scientific & Industrial Research Substituted 1,2,3-triazol-1-yl-methyl-2,3-dihydro-2-methyl-6-nitroimidazo[2,1-b]oxazoles as anti-mycobacterial agents and a process for the preparation thereof
CN107207532B (zh) * 2015-01-29 2019-07-30 南京明德新药研发股份有限公司 抗肺结核病的硝基咪唑衍生物
JP6905506B2 (ja) * 2016-02-26 2021-07-21 大塚製薬株式会社 ピペリジン誘導体
WO2018112842A1 (en) 2016-12-22 2018-06-28 Merck Sharp & Dohme Corp. 6,6-fused heteroaryl piperidine ether allosteric modulators of m4 muscarinic acetylcholine receptor
CN112236141A (zh) 2018-06-11 2021-01-15 大塚制药株式会社 包含德拉马尼的组合物
EP3669873A1 (en) 2018-12-20 2020-06-24 Abivax Quinoline derivatives for use ine the traeatment of inflammation diseases
CN112300192B (zh) * 2019-08-02 2023-08-11 南京长澳医药科技有限公司 硝基咪唑类化合物及其制备方法和用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1253674A (en) 1984-06-13 1989-05-09 Louis J. Manfredo Reaction bonded carbide, nitride, boride, silicide or sulfide bodies
EP0294176A3 (en) 1987-06-02 1989-12-27 Corning Glass Works Lightweight laminated or composite structures
AU6355190A (en) 1989-06-13 1991-01-17 Smithkline Beecham Corporation Inhibition of interleukin-1 and tumor necrosis factor production by monocytes and/or macrophages
US5668127A (en) 1995-06-26 1997-09-16 Pathogenesis Corporation Nitroimidazole antibacterial compounds and methods of use thereof
US6087358A (en) 1995-06-26 2000-07-11 Pathogenesis Corporation Nitro-[2,1-b]imidazopyran compounds and antibacterial uses thereof
JP3174524B2 (ja) 1997-02-21 2001-06-11 日本碍子株式会社 台板の下面清掃機構付きプッシャー型連続炉
JP2001072472A (ja) 1999-06-29 2001-03-21 Ibiden Co Ltd 炭化珪素焼成用治具
EP1142619B1 (en) 1999-09-29 2007-01-24 Ibiden Co., Ltd. Honeycomb filter and ceramic filter assembly
TWI347946B (en) * 2002-10-11 2011-09-01 Otsuka Pharma Co Ltd 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound
MXPA05002414A (es) 2002-10-15 2005-06-22 Otsuka Pharma Co Ltd Compuesto de 4-nitroimidazol 1-sustituido y procedimiento para su produccion.
AU2004285811B2 (en) * 2003-10-31 2008-06-12 Otsuka Pharmaceutical Co., Ltd. 2,3-dihydro-6-nitroimidazo (2,1-B) oxazole compounds for the treatment of tuberculosis
EP1906926B1 (en) * 2005-07-28 2010-12-01 Otsuka Pharmaceutical Co., Ltd. Pharmaceutical composition comprising 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole derivatives

Also Published As

Publication number Publication date
WO2005042542A1 (en) 2005-05-12
KR100851802B1 (ko) 2008-08-13
BRPI0414909A (pt) 2006-11-07
PL1678185T3 (pl) 2009-04-30
AU2004285811B2 (en) 2008-06-12
CY1108481T1 (el) 2014-04-09
CA2539335A1 (en) 2005-05-12
DE602004017037D1 (de) 2008-11-20
HK1097258A1 (zh) 2007-06-22
AR046777A1 (es) 2005-12-21
EP1678185B1 (en) 2008-10-08
US20080119478A1 (en) 2008-05-22
RU2006118794A (ru) 2007-12-10
ES2314460T3 (es) 2009-03-16
TWI335331B (en) 2011-01-01
ATE410430T1 (de) 2008-10-15
MY146646A (en) 2012-09-14
PT1678185E (pt) 2009-01-13
EP1678185A1 (en) 2006-07-12
TW200528460A (en) 2005-09-01
US8163753B2 (en) 2012-04-24
RU2365593C2 (ru) 2009-08-27
KR20060085644A (ko) 2006-07-27
SI1678185T1 (sl) 2009-02-28
AU2004285811A1 (en) 2005-05-12

Similar Documents

Publication Publication Date Title
DK1678185T3 (da) 2,3-dihydro-6-nitroimidazo[2,1-b]oxazolforbindelser til behandling af tuberkulose
EP1555267A4 (en) 2,3-dihydro-6-NITROIMIDAZOç2,1-b] oxazoles
DK1803718T3 (da) 4-Tetrazolyl-4-phenylpiperidin-derivater til behandling af smerter
DK1701941T3 (da) Forbindelser til behandling af sygdomme med celleproliferation
DK1553929T3 (da) Sammensætning med kontrolleret frigivelse.
CY2015036I1 (el) Νεα παραγωγα οξαζολιδινονης
DK1259512T3 (da) Pteridinforbindelser til behandling af psoreasis
DK1651622T3 (da) Fremgangsmåde til fremstilling af 2-(quinoxalin-5-ylsulfonylamino)-benzamidforbindelser
DK1575597T3 (da) Anvendelse af rimexolon til behandling af öjentörhed
NO20053211D0 (no) Forbindelser for behandling av metabolske forstyrrelser.
DK1611108T3 (da) Fremgangsmåde til fremstilling af telmisartan
DK1546122T3 (da) Fremgangsmåde til fremstilling af valsartan
DK1380121T3 (da) Fremgangsmåde til fremstilling af oxazolidinoner
NO20045554L (no) Fremgangsmate for behandling av diabetes
DK1611884T3 (da) Plaster, indeholdende diclofenac
DK1727801T3 (da) Til behandling af smerter anvendelige piperaziner
DK1801108T3 (da) Morpholinforbindelser til behandling af inflammationer.
DK1678135T3 (da) Fremgangsm de til fremstilling af n-amino-substituerede hetorocykliske forbindelser
DK1401277T3 (da) Aminoacetonitrilforbindelser til bekæmpelse af endoparasitter
DK1687297T3 (da) Triazindimerer til behandling af autoimmunsygdomme
DK1838683T3 (da) Fremgangsmåde til fremstilling af [1,4,5]-oxadiazepinderivater
DK2845594T3 (da) Anvendelse af dihydroimidazoloner til behandlingen af hunde.
DK1660485T3 (da) Forbedret fremgangsmåde til fremstilling af alpha-polymorfisk eletriptanhydrobromid
DK1881830T3 (da) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinolin-derivater til behandling af infertilitet
DK3332789T3 (da) Cladribinkur til behandling af multipel sklerose